Related Experiment Video
Updated: Dec 14, 2025

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
Multi-layered proteomic analyses decode compositional and functional effects of cancer mutations on kinase complexes
Martin Mehnert1, Rodolfo Ciuffa2, Fabian Frommelt2
1Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Switzerland. martin.mehnert@hest.ethz.ch.
Genetic mutations can drive disease, but understanding their molecular impact is difficult. This study introduces a proteomic workflow to reveal how mutations in Dyrk2 protein kinase alter cellular processes and link to cancer.
Area of Science:
- Genomics
- Proteomics
- Molecular Biology
Background:
- Genomic data is rapidly expanding, identifying disease-associated mutations.
- Understanding the molecular mechanisms of these mutations is challenging.
Purpose of the Study:
- To develop a multilayered proteomic workflow to investigate how genetic lesions impact the proteome and cellular phenotypes.
- To explore the effects of disease-associated Dyrk2 protein kinase mutations on its complex, activity, and cellular phosphorylation.
Main Methods:
- Development of a multilayered proteomic workflow.
- Expression analysis of disease-associated Dyrk2 mutations.
- Assessment of protein complex composition, topology, and kinase activity.
- Phosphoproteomic profiling of cells.
Main Results:
- Dyrk2 mutations altered protein-protein interactions, complex topology, and kinase activity.
- Mutations affected the phosphorylation of known cancer driver proteins.
- These changes link Dyrk2 mutations to cancer-related biochemical pathways.
Conclusions:
- The developed proteomic workflow effectively reveals mutation-specific molecular changes.
- Genetic lesions exhibit extensive plasticity in their molecular responses.
- Dyrk2 mutations have significant functional consequences relevant to cancer development.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
MAPK Signaling Cascades

